资讯

The Pharma Letter20 分钟
MHRA approves Amgen’s Tepezza for NED
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) yesterday approved Tepezza (teprotumumab (Tepezza). This ...
The Pharma Letter15 分钟
Shionogi pushes 2030 vision forward with $1 billion acquisition
Japanese drugmaker Shionogi (TYO: 4507) is to scale up its pipeline and global ambitions with a deal worth more than $1 ...